Henningfield, Jack
Gauvin, David
Bifari, Francesco
Fant, Reginald
Shram, Megan
Buchhalter, August
Ashworth, Judy
Lanier, Ryan
Pappagallo, Marco
Inturrisi, Charles
Folli, Franco
Traversa, Sergio
Manfredi, Paolo L.
Funding for this research was provided by:
Relmada Therapeutics, Inc.
Article History
Received: 22 November 2021
Accepted: 17 May 2022
First Online: 6 July 2022
Competing interests
: This research was performed at Charles River Laboratories and was sponsored by Relmada Therapeutics. Dr Gauvin is an employee at Charles River Laboratories. Drs. Manfredi, Inturrisi, Pappagallo, Shram, Henningfield, Buchhalter, Ashworth, Lanier, Folli are paid consultants of Relmada Therapeutics. Sergio Traversa is an employee at Relmada Therapeutics. Drs Inturrisi and Manfredi are inventors on esmethadone patents and other patents and patent applications. Francesco Bifari has no competing interests.